Alan F. Denenberg

Davis Polk is advising J.P. Morgan Securities as financial adviser to Medivation, Inc. in connection with its approximately $14 billion acquisition by Pfizer Inc. The acquisition, which is…

Davis Polk advised TerraVia Holdings, Inc. in connection with its sale of a majority interest in the Algenist skincare brand to Algenist Holdings, Inc., an affiliate of Tengram Capital…

Davis Polk advised the joint book-running managers on an SEC-registered debt offering by Alphabet Inc., consisting of $2 billion of 1.998% notes due 2026. Alphabet is a holding company that…

Davis Polk is advising Qatalyst Partners as financial adviser to Citrix Systems, Inc. in connection with the agreement to separate and combine Citrix’s GoTo business with LogMeIn, Inc. in a…

Davis Polk is advising JP Morgan as financial adviser to Sequenom, Inc. in connection with its $371 million acquisition by Laboratory Corporation of America Holdings. The closing of the…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Cree, Inc. in connection with the $850 million sale of its Wolfspeed Power and RF division, which includes the…

Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…

Davis Polk is advising Qatalyst Partners as financial adviser to LinkedIn Corporation in connection with its $26.2 billion acquisition by Microsoft Corp. The deal is expected to close this…

Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by Nevro Corp. of $172.5 million aggregate principal amount of its 1.75%…

Davis Polk is advising JP Morgan as lead financial adviser to Symantec Corporation in connection with its $4.65 billion acquisition of Blue Coat, Inc. The closing of the transaction, which…